Tambayoyi game da Waɗannan Magungunan Arthritis Rheumatoid
Masu maganin TNF su ne magunguna don maganin cututtukan arthritis na rheumatoid. Kamar yadda yake tare da kowace miyagun ƙwayoyi, za su iya tasiri sosai ga wasu mutane kuma ƙasa da haka ga wasu. A nan ne kalli abin da masu haɓakar TNF suke da kuma yadda suke aiki, abin da tasirin su masu tasiri suke, da kuma yadda takamaimai suke kwatanta.
Menene Maƙaryata na TNF?
Masu maganin TNF sun kasance masu sassaucin ra'ayi, kwayoyi masu rikitarwa waɗanda suke cikin magungunan magungunan da ake kira biologics.
Suna aiki ta hanyar zartar da kayan da ake kira ƙwayoyin necrosis tumɓir da ke haifar da ƙonewa. Wasu nazarin halittu don magance cututtuka na rheumatoid sune kwayoyi guda daya.
Labaran kwayoyi sune kwayoyi da suke kama kwayoyin da ke haifar da kumburi da lalacewa. An ba da izini ga mutanen da suke shan wasu magungunan maganin arthritis, irin su DMARDs (cututtuka na maganin maganin maganin ƙwayar cuta), amma ba samun taimako mai yawa ba.
Maɗarin Necrosis Factor ne mai gina jiki wanda aka samar da tsarin tsarin. Yana taka muhimmiyar rawa a yawancin ayyuka na jiki, irin su fatabolism da coagulation, ko clotting, na jini. Wasu sharuɗɗa, ciki har da ciwon daji da cututtuka na asibiti irin su arthritis na rheumatoid, zasu iya haifar da karar da TNF, wanda hakan zai haifar da kumburi.
Kun rigaya sani cewa kwayoyin cutar abu ne da kwayoyin rigakafi suka samar don yaki da antigens irin su ƙwayoyin cuta.
An samar da kwayoyin monoclonal a cikin lab kuma an tsara su don magance kwayoyin musamman, irin su TNF.
Samar da kwatancin masu hana masu amfani da TNF
Yana da mahimmanci a kullun don duba irin kamance da bambance-bambance a tsakanin magunguna lokacin da kai da likitan ka ke yin aiki a kan magani wanda ke da kyau a gare ka. Wasu dalilai da za a yi la'akari da lokacin da za a zabi tsakanin masu saitin TNF shine yadda aka ba kowannensu, sakamakon illa, da kuma farashi.
Enbrel (akasarin) shine farkon magunguna na TNF. Cibiyar Abinci da Druggun Amurka (FDA) ta amince da shi a shekarar 1998. An samo Enbrel ta hanyar gabatar da DNA ta DNA a cikin sassan jikin dabbobi na hamster na kasar don ƙirƙirar sunadaran sarrafawa.
Remicade (infliximab) wani ɓangare ne wanda yake ɗaukar nauyin necrosis factor alpha (TNF-alpha). Shi ne mai gabatarwa na TNF na biyu don zama FDA-yarda, a 1999.
Humira (adalimumab) wani mutum ne wanda aka saba da shi, wanda yake nufin magungunan miyagun ƙwayoyi yana kama da irin kwayoyin halittar mutum, ko da yake an halicce shi a cikin wani lab. Humda ya amince da shi a shekara ta 2002.
Cimzia
Cimzia (certolizumab pegol) shine kadai mai hana TNF cewa masu zama ba su da ƙananan ƙwayoyin cuta saboda kwayoyin sunadarai. Bugu da ƙari, idan aka kwatanta da wasu magungunan TNF, Cimzia ya ruwaito cewa yana da dangantaka mafi girma ga TNF.
Simponi
Simponi (golimumab) wani mai amfani ne na TNF-alpha wanda aka tsara shi don cututtuka na ulcers, psithic arthritis, da sparkylitis ankylosing. An amince a shekarar 2004.
Hanyoyi na gefen TNF Blockers
Babu magani ba tare da tasiri ba. Wasu matsalolin da suka shafi mabudin TNF sun kasance sanannun, suna sa wasu marasa lafiya na arthritis su yi watsi da daukar masu hana TNF .
Amma ga mafi yawan masu goyon baya, amfanin da ya fi yawan haɗari.
Wasu marasa lafiya sunyi kamuwa da kamuwa da cuta yayin da ake kula da su tare da DMARDs ko kwayoyin kwayoyin halitta. (Haka yake daidai da DMARDs.)
Wani bincike na shekara ta 2016 ya gano cewa mutanen da suka dauki wasu magoyacin TNF don maganin wariyar launin fata sunyi sau uku na hadarin bunkasa wasu cututtuka, kamar lymphoma. Wannan shi ne ainihin gaskiyar idan sun kasance a kan dogaro.
Karanta Duk Game da Shi
Arthritis Ba tare da Pain - Miracle na TNF Blockers
Wannan littafi da masanin ilimin lissafi Scott J. Zashin, MD, ya bayyana yadda masu harkar TNF ke aiki da yadda suke kwatanta da sauran maganin cututtuka.
Ya haɗa da labarun nasara da kuma ci gaba da yadda irin wannan magungunan kwayoyi ya canza rayuka.